Literature DB >> 29217750

Overcoming immune evasion in pancreatic cancer: the combination matters.

Patrick Michl1, Sebastian Krug1.   

Abstract

Entities:  

Keywords:  immunotherapy; pancreatic cancer

Mesh：

Year:  2017        PMID： 29217750     DOI： 10.1136/gutjnl-2017-315443

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.

Authors:  Nikita S Sharma; Vineet K Gupta; Vanessa T Garrido; Roey Hadad; Brittany C Durden; Kousik Kesh; Bhuwan Giri; Anthony Ferrantella; Vikas Dudeja; Ashok Saluja; Sulagna Banerjee
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma.

Authors:  Jing Liu; Wenna Jiang; Kaili Zhao; Hongwei Wang; Tianxing Zhou; Weiwei Bai; Xiuchao Wang; Tiansuo Zhao; Chongbiao Huang; Song Gao; Tai Qin; Wenwen Yu; Bo Yang; Xin Li; Danqi Fu; Wei Tan; Shengyu Yang; He Ren; Jihui Hao
Journal:  J Exp Med       Date:  2019-02-07       Impact factor: 14.307

3.  B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma.

Authors:  Qi Chen; Jianxin Wang; Wei Chen; Qi Zhang; Tao Wei; Yue Zhou; Xingyuan Xu; Xueli Bai; Tingbo Liang
Journal:  Cancer Sci       Date:  2019-01-16       Impact factor: 6.716

4.  Downregulated F-Box/LRR-Repeat Protein 7 Facilitates Pancreatic Cancer Metastasis by Regulating Snail1 for Proteasomal Degradation.

Authors:  Liang Tang; Meng Ji; Xing Liang; Danlei Chen; Anan Liu; Guang Yang; Ligang Shi; Zhiping Fu; Chenghao Shao
Journal:  Front Genet       Date:  2021-06-24       Impact factor: 4.599

5.  GFAT1/HBP/O-GlcNAcylation Axis Regulates β-Catenin Activity to Promote Pancreatic Cancer Aggressiveness.

Authors:  Chunzeng Jia; Hengchao Li; Deliang Fu; Yu Lan
Journal:  Biomed Res Int       Date:  2020-02-15       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.